News for hackers. Stuff that matters.
Re:Merck's molnupiravir should not be approved by jleyank on Friday December 24, 2021 @01:44PM (#29676426)
Sadly, this is also what remdesivir does, although its an infusion. Also, the evolutionary pressure from vaccine-induced or natural antibodies also encourage mutations. The gamble is always complexity-related - will a random change help or hurt more.

People have also suggested a mixture of the Pfizer and Merck oral meds in order to reduce the chance of (quickly?) developing resistance to the protease. Similar to how HIV cocktails are used.

There are no comments on this comment yet.